Pure Bioscience, Inc. (PURE) Reports Q3 Loss of $0.04/Share

Pure Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $207 thousand, versus $128 million reported last year.

For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c
• SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59